Treating Hypertension and Dyslipidemia in Patients with Diabetes: The Goals and How to Reach Them

Diabetology
Curriculum:
N/A
Credits:
1 AMA PRA Category 1 Credits
Launch Date:
21-Sep-12
Expiration Date:
The accreditation for this activity has expired.

Primary Audience:

Primary Care Providers (Mds, Dos, Nps, Pas) And Their Office Staff.

Relevant Terms:

Hypertension, Dyslipidemia, Cardiovascular Disease

David Erani, MD

David Erani, MD
Director of Medical Programs
Joslin Diabetes Center
Boston, MA

Dr. David Erani has joined our team as Director of Medical Programs for the Joslin Affiliates network. He will also hold this same role in Healthcare Services.
 
David first came to Joslin 15 years ago as a fellow. A native New Yorker, after completing his fellowship, he returned to New York to join the staff of Bronx-Lebanon Hospital where he rose to the rank of Chief of Endocrinology, Diabetes, and Metabolism. In 2008, he was recruited to Diabetes America where he served as Chief Medical Officer of the company which operates diabetes centers throughout the state of Texas. For the past 18 months, he served as Medical Director of the Joslin Affiliate at Cypress Fairbanks Medical Center in Houston.

In Affiliated Programs, he will work with the Boston team to conduct annual and targeted site visits for Affiliates, and to develop our inpatient offering for Affiliates. He will share insights gained from his experience in a variety of clinical settings, including Joslin Diabetes Center, a South Bronx diabetes center, a multisite diabetes practice in Texas, and the Joslin Affiliate at Cypress Fairbanks Medical Center Hospital in Houston.
1. Define the recommended treatment goals for dyslipidemia and hypertension in patients with diabetes
2. Describe the different classes of available lipid-lowering medications and anti-hypertensive agents and the mechanisms of action
3. Describe currently available evidence-based therapies for treating dyslipidemia and hypertension to get patients to goal

CME Release Date: 09/21/12
CME Expiration Date: 09/20/15
 
This Internet enduring material activity was developed as an original manuscript by the faculty. 
 
Statement of Need
Cardiovascular deaths are epidemic, particularly among people with diabetes and related conditions such as the Cardiometabolic Syndrome and other similar clusters of risk-conferring factors. From the perspective of diabetes alone, the CDC reports that data from 2004 indicated that heart disease was noted on 68% of diabetes-related death certificates and stroke on 16% of diabetes-related death certificates among people aged 65 years or older. Adults with diabetes have heart disease death rates about 2 to 4 times higher than adults without diabetes, and in the same population, the risk for stroke is 2 to 4 times higher than the general population.
 
This activity was developed in response to the current epidemic of diabetes as well as the various complications such as hypertension and dyslipidemia that are associated with it. These conditions have created a mandate for clinicians to address this spectrum of complex conditions with an equally as complex care delivery capability. Since primary care clinicians oversee the management of most patients with diabetes, they are in the best position to identify patient needs, initiate treatments and/or refer for specialty support, and provide ongoing monitoring for complications.
 
Target Audience
This certified CME Internet enduring material activity has been developed for primary care providers (MDs, DOs, NPs, PAs) and their office staff. There is no fee to participate in this activity.
 
 
Faculty and Disclosures
 
David Erani, MD
Director of Medical Programs
Joslin Diabetes Center
Boston, MA

Disclosure: Dr. David Erani is on the speakers bureau for Amylin Pharmaceuticals, Inc.  and sanofi U.S LLC.
 
Planning Committee
 
Richard S. Beaser, MD**
Associate Clinical Professor of Medicine
Harvard Medical School
Medical Executive Director
Professional Education
Joslin Diabetes Center
Boston, MA
 
Disclosure: Dr. Richard S. Beaser is a consultant for AstraZeneca/Bristol-Meyers Squibb Company, CeQur Ltd. and Janssen Pharmaceuticals.
 
Julie A. Brown**
Director
Professional Education
Joslin Diabetes Center
Boston, MA
 
Disclosure: Julie A. Brown is a consultant for Bristol-Meyers Squibb Company.
 
Karen J. Kuc**
Assistant Director, Grants and Projects
Professional Education
Joslin Diabetes Center
Boston, MA
 
Disclosure: Karen J. Kuc has no relevant financial relationships.
 
James E. Neighbours, MEd**
Associate Director, Education Design
Professional Education
Joslin Diabetes Center
Boston, MA
 
Disclosure: James E. Neighbours has no relevant financial relationships.
 
**Also on the CME Advisory Committee
 
CME Advisory Committee
 
Enrique Caballero, MD
Director, Medical Affairs
Professional Education
Director, Latino Diabetes Initiative
Joslin Diabetes Center
Boston, MA
 
Disclosure: Dr. Enrique Caballero is a consultant and on the speakers bureau and scientific advisory board for Amylin Pharmaceuticals, Inc., AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Daiichi Sankyo, Inc., and Eli Lilly and Company.
 
Jerry Cavallerano, OD, PhD
Optometrist
Beetham Eye Institute
Joslin Diabetes Center
Boston, MA
 
Disclosure: Dr. Jerry Cavallerano has no relevant financial relationships.
 
A. Patrick Egan, MD
Family Practice
Internal Medicine Specialist
Dorchester House Multi-Service Center
Boston, MA
 
Disclosure: Dr. A. Patrick Egan has no relevant financial relationships.
 
Ann E. Goebel-Fabbri, PhD
Instructor in Psychiatry
Harvard Medical School
Psychologist
Behavioral and Mental Health Unit
Joslin Diabetes Center
Boston, MA
 
Disclosure: Anne E. Goebel-Fabbri has no relevant financial relationships.
 
Osama Hamdy, MD, PhD, FACE
Assistant Professor of Medicine
Harvard Medical School
Medical Director, Obesity Clinical Program
Joslin Diabetes Center
Boston, MA
 
Disclosure: Dr. Osama Hamdy is on the speakers bureau for Amylin Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Merck & Co., Inc., Novo Nordisk Inc., sanofi-aventis U.S., and Takeda Pharmaceuticals North America, Inc.
 
Robert C. Stanton, MD
Associate Professor of Medicine
Harvard Medical School
Chief of Nephrology
Joslin Diabetes Center
Boston, MA
 
Disclosure: Dr. Robert C. Stanton has no relevant financial relationships.
 
Howard A. Wolpert, MD
Assistant Professor of Medicine
Harvard Medical School
Director, Insulin Pump Program
Senior Physician
Joslin Diabetes Center
Boston, MA
 
Disclosure: Dr. Howard A. Wolpert is a consultant for Abbott Diabetes Care; Becton, Dickinson and Company; Insulet Corporation; and Novo Nordisk, Inc.
 
 
Accreditation and Designation of Credit
Joslin Diabetes Center, Boston, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Joslin Diabetes Center designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit the commensurate with the extent of their participation in the activity.
 
Participants not eligible for continuing medical education credit will receive a certificate of participation.
 
This CME activity was planned and produced in accordance with ACCME Essentials.
 
Credit Instructions
  • Read the learning objectives, accreditation information, and faculty disclosures at the beginning of the activity.
  • Read the monograph.
  • Complete the posttest and evaluation.
  • Physicians who receive a grade of 70% or better on the posttest and who complete the evaluation will receive immediate CME credit.
  • All other participants who receive a grade of 70% or better on the posttest and who complete the evaluation will receive a certificate of participation.
 
Acknowledgement
This activity is sponsored by Joslin Diabetes Center.
 
This activity is supported through educational grants provided by Pfizer Inc, GlaxoSMithKline and Lilly USA, LLC.
 
Questions About This Activity
For any questions regarding this activity, contact the accredited provider for this CME activity: cme@joslin.harvard.edu
 
 
COURSE VIEWING REQUIREMENTS
Supported Browsers:
Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 5.0+ for Mac OSX 10.5 and above

For video playback, install the latest version of Flash or Quicktime.